- Trials with a EudraCT protocol (9)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
9 result(s) found for: Non-allergic Asthma.
Displaying page 1 of 1.
EudraCT Number: 2013-003098-88 | Sponsor Protocol Number: PED/VITD/1 | Start Date*: 2014-02-26 |
Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar) [...] | ||
Full Title: An open, controlled, double-blind, with placebo clinical trial and randomized in subgroups of pediatric patients with allergic and non-allergic asthma, with deficiency, insufficiency or normal leve... | ||
Medical condition: One hundred and sixty children with allergic or non-allergic asthma, deficit, insufficiency or normal levels of Vitamin D. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003795-35 | Sponsor Protocol Number: Griac001 | Start Date*: 2006-10-03 | |||||||||||
Sponsor Name:University Medical Center Groningen | |||||||||||||
Full Title: Mannitol inhalations as a faster procedure for testing of airways hyperresponsiveness | |||||||||||||
Medical condition: Detection of airway hyperresponsiveness in patients with asthma or COPD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023981-27 | Sponsor Protocol Number: Acti-SCIPE-001 | Start Date*: 2011-03-08 | |||||||||||
Sponsor Name:Activaero GmbH | |||||||||||||
Full Title: An Open-Label Randomized Pilot Trial to Evaluate Tolerability, Safety and Applicability of AKITA Inhaled Budesonide Suspension in Children aged 3-11 years with Mild to Moderate Asthma | |||||||||||||
Medical condition: Allergic or non-allergic mild to moderate asthma in children aged three to eleven years. Affected children need to suffer from mild to moderate asthma according to ATS definition at least for 6 mon... | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014640-11 | Sponsor Protocol Number: Acti-AICS-001 | Start Date*: 2010-01-26 | |||||||||||
Sponsor Name:Activaero GmbH | |||||||||||||
Full Title: A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate Tolerability, Safety and Efficacy of AKITA Inhaled Steroid Suspension for Inhalation (AICS) in Subjects with Asthma Requiring Chroni... | |||||||||||||
Medical condition: Subjects with Asthma Requiring Chronic Oral Corticosteroid Treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001644-21 | Sponsor Protocol Number: MEA115661 | Start Date*: 2013-06-24 |
Sponsor Name:GlaxoSmithKline Research & Development Ltd | ||
Full Title: MEA115661: A multi-centre, open-label, long-term safety study of mepolizumab in asthmatic subjects who participated in the MEA115588 or MEA115575 trials. | ||
Medical condition: Subjects with Severe Asthma | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) GB (Completed) DE (Completed) IT (Completed) ES (Completed) NL (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-000314-54 | Sponsor Protocol Number: 201312 | Start Date*: 2014-04-10 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: Study 201312: A Multi-Centre, Open-Label, Study of Mepolizumab in a Subset of Subjects with a History of Life Threatening/Seriously Debilitating Asthma Who Participated in the MEA115661 Trial | |||||||||||||
Medical condition: Subjects with Severe Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) DE (Completed) NL (Completed) ES (Completed) GB (Completed) BE (Completed) CZ (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001549-13 | Sponsor Protocol Number: GB39242 | Start Date*: 2016-12-16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Genentech, Inc. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A PHASE IIB, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO ASSESS THE EFFICACY AND SAFETY OF MSTT1041A IN PATIENTS WITH UNCONTROLLED SEVERE ASTHMA | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Uncontrolled Severe Asthma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Completed) DE (Completed) CZ (Completed) PL (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-001643-51 | Sponsor Protocol Number: MEA115666 | Start Date*: 2012-09-17 |
Sponsor Name:GlaxoSmithKline Research and Development Limited | ||
Full Title: MEA115666: A multi-centre, open-label, long term safety study of mepolizumab in asthmatic subjects who participated in the MEA112997 trial. | ||
Medical condition: Subjects with severe, refractory asthma and a history of eosinophilic inflammation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-020079-22 | Sponsor Protocol Number: DG40.08 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:STALLERGENES S.A. | |||||||||||||
Full Title: Determination of sensitivity and specificity of five solutions of allergen extract (5 grasses, birch, ragweed pollens and Dermatophagoides pteronyssinus and Dermatophagoides farinae mites) for diag... | |||||||||||||
Medical condition: Allergy to grass pollen Allergy to birch pollen Allergy to ragweed pollen Allergy to mites | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.